Prostaglandins, Leukotrienes and Essential Fatty Acids
Volume 82, Issue 2 , Pages 131-139 , February 2010

Hypertonic environment elicits cyclooxygenase-2-driven prostaglandin E2 generation by colon cancer cells: Role of cytosolic phospholipase A2-α and kinase signaling pathways

  • Luciana B. Gentile

      Affiliations

    • Divisão de Biologia Celular, Coordenação de Pesquisa, Instituto Nacional de Câncer, Rio de Janeiro, RJ 20231-050, Brazil
    • Programa de Pós-Graduação em Ciências Morfológicas, Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ 21941-902, Brazil
    • ,
  • Bruno Piva

      Affiliations

    • Laboratório de Inflamação, Programa de Imunobiologia, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Av. Carlos Chagas Filho 373, Bloco C, room C1-024, Rio de Janeiro, RJ, CEP 21941-902, Brazil
    • ,
  • Bianca C. Capizzani

      Affiliations

    • Laboratório de Inflamação, Programa de Imunobiologia, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Av. Carlos Chagas Filho 373, Bloco C, room C1-024, Rio de Janeiro, RJ, CEP 21941-902, Brazil
    • ,
  • Luiz G.B. Furlaneto

      Affiliations

    • Divisão de Biologia Celular, Coordenação de Pesquisa, Instituto Nacional de Câncer, Rio de Janeiro, RJ 20231-050, Brazil
    • ,
  • Luciana S. Moreira

      Affiliations

    • Divisão de Biologia Celular, Coordenação de Pesquisa, Instituto Nacional de Câncer, Rio de Janeiro, RJ 20231-050, Brazil
    • ,
  • Daniel Zamith-Miranda

      Affiliations

    • Laboratório de Inflamação, Programa de Imunobiologia, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Av. Carlos Chagas Filho 373, Bloco C, room C1-024, Rio de Janeiro, RJ, CEP 21941-902, Brazil
    • ,
  • Bruno L. Diaz

      Affiliations

    • Laboratório de Inflamação, Programa de Imunobiologia, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Av. Carlos Chagas Filho 373, Bloco C, room C1-024, Rio de Janeiro, RJ, CEP 21941-902, Brazil
    • Corresponding Author InformationCorresponding author. Tel.: +552125626509; fax: +552122808193.

Received 5 December 2008 ,Revised 11 November 2009 ,Accepted 12 November 2009.

References 

  1. Fukuda R, Kelly B, Semenza GL. Vascular endothelial growth factor gene expression in colon cancer cells exposed to prostaglandin E2 Is mediated by hypoxia-inducible factor 1. Cancer Res. 2003;63:2330
  2. Sheng H, Shao J, Washington MK, DuBois RN. Prostaglandin E2 increases growth and motility of colorectal carcinoma cells. J. Biol. Chem. 2001;276:18075–18081
  3. Tomozawa S, Tsuno NH, Sunami E, Hatano K, Kitayama J, Osada T, et al. Cyclooxygenase-2 overexpression correlates with tumour recurrence, especially haematogenous metastasis, of colorectal cancer. Br. J. Cancer. 2000;83:324–328
  4. Wang D, Wang H, Brown J, Daikoku T, Ning W, Shi Q, et al. CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer. J. Exp. Med. 2006;203:941–951
  5. Castellone MD, Teramoto H, Williams BO, Druey KM, Gutkind JS. Prostaglandin E2 promotes colon cancer cell growth through a Gs-Axin-{beta}-catenin signaling axis. Science. 2005;310:1504–1510
  6. Sonoshita M, Takaku K, Sasaki N, Sugimoto Y, Ushikubi F, Narumiya S, et al. Acceleration of intestinal polyposis through prostaglandin receptor EP2 in APCΔ716 knockout mice. Nat. Med. 2001;7:1048–1051
  7. Watanabe K, Kawamori T, Nakatsugi S, Ohta T, Ohuchida S, Yamamoto H, et al. Role of the prostaglandin E receptor subtype EP1 in colon carcinogenesis. Cancer Res. 1999;59:5093–5096
  8. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology. 1994;107:1183–1188
  9. Sano H, Kawahito Y, Wilder RL, Hashiramoto A, Mukai S, Asai K, et al. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res. 1995;55:3785–3789
  10. Sheng H, Shao J, Kirkland SC, Isakson P, Coffey RJ, Morrow J, et al. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J. Clin. Invest. 1997;99:2254–2259
  11. Smith WL, DeWitt DL, Garavito RM. Cyclooxygenases: structural, cellular, and molecular biology. Annu. Rev. Biochem. 2000;69(145-82):145–182
  12. Yoshimatsu K, Golijanin D, Paty PB, Soslow RA, Jakobsson PJ, DeLellis RA, et al. Inducible microsomal prostaglandin E synthase is overexpressed in colorectal adenomas and cancer. Clin. Cancer Res. 2001;7:3971–3976
  13. Taketo MM. Cyclooxygenase-2 inhibitors in tumorigenesis (Part II). J. Natl. Cancer Inst. 1998;90:1609–1620
  14. Oshima M, Dinchuk JE, Kargman SL, Oshima H, Hancock B, Kwong E, et al. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell. 1996;87:803–809
  15. Steinbach G, Lynch PM, Phillips RK, Wallace MH, Hawk E, Gordon GB, et al. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N. Engl. J. Med. 2000;342:1946–1952
  16. Solomon SD, McMurray JJ, Pfeffer MA, Wittes J, Fowler R, Finn P, et al. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N. Engl. J. Med. 2005;352:1071–1080
  17. Bresalier RS, Sandler RS, Quan H, Bolognese JA, Oxenius B, Horgan K, et al. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N. Engl. J. Med. 2005;352:1092–1102
  18. Diaz BL, Arm JP. Phospholipase A(2). Prostaglandins Leukot. Essent. Fatty Acids. 2003;69:87–97
  19. Schaloske RH, Dennis EA. The phospholipase A2 superfamily and its group numbering system. Biochim. Biophys. Acta (BBA) – Molec. Cell Biol. Lipids. 2006;1761:1246–1259
  20. Ghosh M, Tucker DE, Burchett SA, Leslie CC. Properties of the Group IV phospholipase A(2) family. Prog. Lipid. Res. 2006;45:487–510
  21. Durstin M, Durstin S, Molski TFP, Becker EL, Sha'afi RI. Cytoplasmic phospholipase A2 translocates to membrane fraction in human neutrophils activated by stimuli that phosphorylate mitogen-activated protein kinase. PNAS. 1994;91:3142–3146
  22. Lin LL, Wartmann M, Lin AY, Knopf JL, Seth A, Davis RJ. cPLA2 is phosphorylated and activated by MAP kinase. Cell. 1993;72:269–278
  23. Nemenoff RA, Winitz S, Qian NX, Van Putten V, Johnson GL, Heasley LE. Phosphorylation and activation of a high molecular weight form of phospholipase A2 by p42 microtubule-associated protein 2 kinase and protein kinase C. J. Biol. Chem. 1993;268:1960–1964
  24. Gijon MA, Spencer DM, Siddiqi AR, Bonventre JV, Leslie CC. Cytosolic phospholipase A2 is required for macrophage arachidonic acid release by agonists that Do and Do not mobilize calcium. Novel role of mitogen-activated protein kinase pathways in cytosolic phospholipase A2 regulation. J. Biol. Chem. 2000;275:20146–20156
  25. Takaku K, Sonoshita M, Sasaki N, Uozumi N, Doi Y, Shimizu T, et al. Suppression of intestinal polyposis in Apc(delta 716) knockout mice by an additional mutation in the cytosolic phospholipase A(2) gene. J. Biol. Chem. 2000;275:34013–34016
  26. Hong KH, Bonventre JC, O'Leary E, Bonventre JV, Lander ES. Deletion of cytosolic phospholipase A(2) suppresses Apc(Min)-induced tumorigenesis. Proc. Natl. Acad. Sci. USA. 2001;98:3935–3939
  27. Panel V, Boelle PY, Ayala-Sanmartin J, Jouniaux AM, Hamelin R, Masliah J, et al. Cytoplasmic phospholipase A2 expression in human colon adenocarcinoma is correlated with cyclooxygenase-2 expression and contributes to prostaglandin E2 production. Cancer Lett. 2006;243:255–263
  28. Dong M, Guda K, Nambiar PR, Rezaie A, Belinsky GS, Lambeau G, et al. Inverse association between phospholipase A2 and COX-2 expression during mouse colon tumorigenesis. Carcinogenesis. 2003;24:307–315
  29. Ilsley JNM, Nakanishi M, Flynn C, Belinsky GS, De Guise S, Adib JN, et al. Cytoplasmic phospholipase A2 deletion enhances colon tumorigenesis. Cancer Res. 2005;65:2636–2643
  30. Cao Y, Pearman AT, Zimmerman GA, McIntyre TM, Prescott SM. Intracellular unesterified arachidonic acid signals apoptosis. Proc. Natl. Acad. Sci. USA. 2000;97:11280–11285
  31. Brash AR. Arachidonic acid as a bioactive molecule. J. Clin. Invest. 2001;107:1339–1345
  32. Taketo MM, Sonoshita M. Phospolipase A2 and apoptosis. Biochim. Biophys. Acta. 2002;1585:72–76
  33. Levine LAWR. Does the release of arachidonic acid from cells play a role in cancer chemoprevention?. FASEB J. 2003;17:800–802
  34. Nakanishi M, Rosenberg DW. Roles of cPLA2[alpha] and arachidonic acid in cancer. Biochim. Biophys. Acta (BBA) – Molec. Cell Biol. Lipids. 1761;1335-1343:2006
  35. Ding LA, Li JS. Gut in diseases: physiological elements and their clinical significance. World J. Gastroenterol. 2003;9:2385–2389
  36. Naftalin RJ, Pedley KC. Video enhanced imaging of the fluorescent Na+ probe SBFI indicates that colonic crypts absorb fluid by generating a hypertonic interstitial fluid. FEBS Lett. 1990;260:187–194
  37. Powell DW. Dogma destroyed: colonic crypts absorb. J. Clin. Invest. 1995;96:2102–2103
  38. Thiagarajah JR, Jayaraman S, Naftalin RJ, Verkman AS. In vivo fluorescence measurement of Na(+) concentration in the pericryptal space of mouse descending colon. Am. J. Physiol. Cell Physiol. 2001;281:C1898–C1903
  39. Yang T, Zhang A, Honeggar M, Kohan DE, Mizel D, Sanders K, et al. Hypertonic Induction of COX-2 in collecting duct cells by reactive oxygen species of mitochondrial origin. J. Biol. Chem. 2005;280:34966–34973
  40. Yang T, Huang Y, Heasley LE, Berl T, Schnermann JB, Briggs JP. MAPK mediation of hypertonicity-stimulated cyclooxygenase-2 expression in renal medullary collecting duct cells. J. Biol. Chem. 2000;275:23281–23286
  41. Arbabi S, Rosengart MR, Garcia I, Jelacic S, Maier RV. Epithelial cyclooxygenase-2 expression: a model for pathogenesis of colon cancer. J. Surg. Res. 2001;97:60–64
  42. Lim WC, Park M, Bahn JJ, Inoue H, Lee YJ. Hypertonic sodium chloride induction of cyclooxygenase-2 occurs independently of NF-[kappa]B and is inhibited by the glucocorticoid receptor in A549 cells. FEBS Lett. 2005;579:5430–5436
  43. Galcheva-Gargova Z, Derijard B, Wu IH, Davis RJ. An osmosensing signal transduction pathway in mammalian cells. Science. 1994;265:806–808
  44. Han J, Lee JD, Bibbs L, Ulevitch RJ. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science. 1994;265:808–811
  45. Johnson GL, Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science. 2002;298:1911–1912
  46. Rennefahrt U, Janakiraman M, Ollinger R, Troppmair J. Stress kinase signaling in cancer: fact or fiction?. Cancer Lett. 2005;217:1–9
  47. Hardwick JC, van den Brink GR, Offerhaus GJ, van Deventer SJ, Peppelenbosch MP. NF-kappaB, p38 MAPK and JNK are highly expressed and active in the stroma of human colonic adenomatous polyps. Oncogene. 2001;20:819–827
  48. Fang JY, Richardson BC. The MAPK signalling pathways and colorectal cancer. Lancet Oncol. 2005;6:322–327
  49. Seno K, Okuno T, Nishi K, Murakami Y, Watanabe F, Matsuura T, et al. Pyrrolidine Inhibitors of Human Cytosolic Phospholipase A2. J. Med. Chem. 2000;43:1041–1044
  50. Fujishima H, Sanchez Mejia RO, Bingham CO, Lam BK, Sapirstein A, Bonventre JV, et al. Cytosolic phospholipase A2 is essential for both the immediate and the delayed phases of eicosanoid generation in mouse bone marrow-derived mast cells. Proc. Natl. Acad. Sci. USA. 1999;96:4803–4807
  51. Sapirstein A, Saito H, Texel SJ, Samad TA, O'Leary E, Bonventre JV. Cytosolic phospholipase A2{alpha} regulates induction of brain cyclooxygenase-2 in a mouse model of inflammation. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005;288:R1774–R1782
  52. Reinehr R, Schliess F, Haussinger D. Hyperosmolarity and CD95L trigger CD95/EGFR association and tyrosine phosphorylation of CD95 as prerequisites for CD95 membrane trafficking and DISC formation. FASEB J. 2003;17:731–733
  53. Margolis BL, Holub BJ, Troyer DA, Skorecki KL. Epidermal growth factor stimulates phospholipase A2 in vasopressin-treated rat glomerular mesangial cells. Biochem. J. 1988;256:469–474
  54. Balsinde J, Balboa MA, Insel PA, Dennis EA. Regulation and inhibition of phospholipase A2. Annu. Rev. Pharmacol. Toxicol. 1999;39:175–189
  55. Mounier CM, Ghomashchi F, Lindsay MR, James S, Singer AG, Parton RG, et al. Arachidonic acid release from mammalian cells transfected with human groups IIA and X secreted phospholipase A2 Occurs predominantly during the secretory process and with the involvement of cytosolic phospholipase A2-{alpha}. J. Biol. Chem. 2004;279:25024–25038
  56. Murakami M, Kuwata H, Amakasu Y, Shimbara S, Nakatani Y, Atsumi G, et al. Prostaglandin E2 amplifies cytosolic phospholipase A2- and cyclooxygenase-2-dependent delayed prostaglandin E2 generation in mouse osteoblastic cells. Enhancement by secretory phospholipase A2. J. Biol. Chem. 1997;272:19891–19897
  57. Moreira LS, Piva B, Gentile LB, Mesquita-Santos FP, D'Avila H, Maya-Monteiro CM, et al. Cytosolic phospholipase A2-driven PGE2 synthesis within unsaturated fatty acids-induced lipid bodies of epithelial cells. Biochim. Biophys. Acta (BBA) – Molec. Cell Biol. Lipids. 1791;156-165:2009
  58. Accioly MT, Pacheco P, Maya-Monteiro CM, Carrossini N, Robbs BK, Oliveira SS, et al. Lipid bodies are reservoirs of cyclooxygenase-2 and sites of prostaglandin-E2 synthesis in colon cancer cells. Cancer Res. 2008;68:1732–1740

☆ Funded by BZG.

PII: S0952-3278(09)00199-9

doi: 10.1016/j.plefa.2009.11.005

Prostaglandins, Leukotrienes and Essential Fatty Acids
Volume 82, Issue 2 , Pages 131-139 , February 2010

Article Tools

* Image Usage & Resolution